TNDM Put Call Ratio at 0.41 Signals Bullish Investor Sentiment Following Bank of America Upgrade

Bank of America Securities made a notable move on February 20, 2026, upgrading its stance on Tandem Diabetes Care from Underperform to Neutral. This rating shift reflects a more positive outlook for the medical device company, and market indicators suggest investors are taking a similarly optimistic position. The put call ratio for TNDM has settled at 0.41, a level that indicates strong bullish sentiment among traders today and in the days ahead.

Bank of America Securities Raises Rating With Path to Higher Valuations

The upgrade from Underperform to Neutral represents a meaningful change in Bank of America’s assessment of TNDM’s prospects. As of February 4, 2026, the consensus among analysts points to significant upside potential. The average one-year price target stands at $24.90 per share, suggesting a 34.43% gain from the most recent closing price of $18.52. Forecasts range widely, from a conservative $14.14 to an ambitious $57.75, reflecting different views on the company’s growth trajectory.

Revenue projections for the coming year total $1,133 million, representing growth of 12.51% year-over-year. The non-GAAP earnings per share forecast is set at 0.01, indicating continued improvement in the company’s financial performance as it scales operations.

Put Call Ratio Reveals Market’s Bullish Bias Today

The put call ratio of 0.41 provides critical insight into investor psychology surrounding TNDM. A reading below 1.0 typically signals bullish market conditions, as it indicates fewer protective puts relative to call options. This ratio tells us that today’s options traders are expressing confidence in a price increase, aligning with the analyst upgrades and improving fundamentals. Investors monitoring sentiment indicators should note that this put call ratio level historically correlates with positive near-term price momentum.

Institutional Investors Show Mixed Activity in Recent Quarter

Fund sentiment remains significant, with 456 institutions and funds maintaining positions in Tandem Diabetes Care. This represents a slight pullback of 53 owners (10.41%) compared to the previous quarter. However, the average portfolio allocation to TNDM across all institutional holders has actually increased to 0.10%, up 4.36%, suggesting that remaining shareholders have increased conviction.

Total institutional holdings have declined marginally by 2.22% to 90,349,000 shares over the three-month period, indicating selective trimming rather than a broad retreat from the position.

Top Shareholders Adjust Positions With Notable Rebalancing

Several major shareholders have made meaningful changes to their TNDM stakes:

Sessa Capital IM maintains the largest position with 5,000,000 shares (7.37% ownership), unchanged from the previous quarter—a sign of sustained confidence.

IJR – iShares Core S&P Small-Cap ETF holds 3,968,000 shares representing 5.85% of the company. The fund reduced its stake from 4,058,000 shares (a 2.28% decrease) and trimmed its overall portfolio allocation to TNDM by 5.69%.

ArrowMark Colorado Holdings experienced more significant movements, cutting holdings from 3,691,000 to 2,890,000 shares (a 27.74% reduction). Interestingly, the firm increased its portfolio weighting in TNDM by 67.95%, suggesting it rebalanced toward quality while maintaining strategic exposure.

GW&K Investment Management holds steady with 2,675,000 shares (3.95% ownership), with no changes recorded in the latest quarter.

VTSMX – Vanguard Total Stock Market Index Fund Investor Shares added modestly to its position, increasing from 2,072,000 to 2,150,000 shares (a 3.59% gain). However, the fund decreased its overall TNDM portfolio allocation by 9.97%, reflecting broader rebalancing across its holdings.

What the Data Suggests for TNDM Investors

The combination of analyst upgrades, improving put call ratio readings, and selective institutional support paints a mixed but tentatively optimistic picture. The 0.41 put call ratio today represents a genuine shift in market sentiment, with options traders positioning for further gains. While institutional ownership has declined slightly, the committed shareholders remaining have increased their conviction, and Bank of America’s upgrade adds credibility to the bullish case. Investors considering TNDM should monitor both the put call ratio as a real-time sentiment gauge and upcoming earnings reports to validate the 34% upside thesis.